Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Is there a link between progranulin, obesity, and parameters of the metabolic syndrome in children? Findings from a
Petra Niklowitz1, Juliane Rothermel1, Nina Lass1
1Vestische Hospital for Children and Adolescents Datteln, University of Witten/Herdecke, Datteln, Germany.
Insights
Progranulin levels did not differ between obese and normal-weight children and were not linked to insulin resistance or metabolic syndrome in obese youth. These findings do not support progranulin
Area of Science:
- Pediatric Endocrinology
- Metabolic Research
- Inflammatory Cytokines
Background:
- Progranulin, an inflammatory cytokine, is hypothesized to influence obesity and related conditions like insulin resistance.
- Understanding the role of progranulin in pediatric obesity is crucial for developing targeted interventions.
Purpose of the Study:
- To investigate the association between progranulin levels and obesity parameters, insulin resistance, and metabolic syndrome in obese children.
- To analyze the longitudinal changes in progranulin during and after a lifestyle intervention in obese children.
Main Methods:
- A longitudinal study involving 88 obese children and 23 normal-weight controls.
- Measurements included progranulin, leptin, BMI-SDS, body fat, lipids, transaminases, HOMA-IR, and blood pressure at baseline, 1 year, and 2 years.
- Statistical analyses included cross-sectional and longitudinal multiple linear regression.
Main Results:
- Progranulin concentrations were similar between obese and normal-weight children.
- Progranulin levels decreased significantly during and after lifestyle intervention, irrespective of BMI-SDS changes.
- No significant association was found between progranulin and insulin resistance (HOMA-IR), metabolic syndrome parameters, or transaminases.
- Progranulin showed a significant negative correlation with age.
Conclusions:
- The study's findings do not support the hypothesis that progranulin is a key mediator linking childhood obesity to insulin resistance and metabolic syndrome.
- Further research may be needed to explore other potential roles of progranulin in pediatric metabolic health.
Background:
The inflammatory cytokine progranulin has been proposed to play a role in obesity and its associated comorbidities such as insulin resistance.
Objective:
In a longitudinal study, we analyzed the links between progranulin, parameters of fat mass, insulin resistance, and metabolic syndrome (MetS) in obese children.
Methods:
We measured the following parameters in 88 obese children at baseline, at the end of a 1-year lifestyle intervention and 1-year later (=2 years after baseline): progranulin, bioactive leptin, body mass index-SD score (BMI-SDS), waist circumference, body fat based on skinfold measurements and bioimpedance analyses, lipids, transaminases, insulin resistance index homeostasis model assessment (HOMA), and blood pressure. As a control, we determined progranulin in 23 normal-weight children.
Results:
The progranulin concentrations did not differ significantly (P = .795) between obese and normal-weight children. Progranulin concentrations decreased significantly during and after the lifestyle intervention in children with and without decrease of BMI-SDS. There was no relationship between progranulin concentrations and pubertal stage or gender. Progranulin was not significantly associated with insulin resistance HOMA, parameters of the MetS or transaminases both in cross-sectional and longitudinal multiple linear regression analyses adjusted to multiple confounders. Progranulin was significantly, negatively related to age (b-coefficient -1.24 ± .97, P = .012, r2 = .07).
Conclusions:
Our data do not support the hypothesis that progranulin is an important link between obesity, insulin resistance, and MetS in childhood.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Related Concept Videos
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
05:10Multidisciplinary Approach to Obesity Management: A Case Report
08:00Studying Brain Function in Children Using Magnetoencephalography
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Longitudinal Studies